| Mesoporous silica nanoparticles: synthesis methods and their therapeutic use-recent advances M Ghaferi, M Koohi Moftakhari Esfahani, A Raza, S Al Harthi, ... Journal of Drug Targeting 29 (2), 131-154, 2021 | 80 | 2021 |
| Nasal delivery of donepezil HCl-loaded hydrogels for the treatment of Alzheimer’s disease S Al Harthi, SE Alavi, MA Radwan, MM El Khatib, IA AlSarra Scientific reports 9 (1), 9563, 2019 | 79 | 2019 |
| Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma H Ebrahimi Shahmabadi, F Movahedi, M Koohi Moftakhari Esfahani, ... Tumor Biology 35, 4799-4806, 2014 | 70 | 2014 |
| Glucagon-like peptide-1 receptor agonists and strategies to improve their efficiency SE Alavi, PJ Cabot, PM Moyle Molecular Pharmaceutics, 2019 | 65 | 2019 |
| Enhanced Efficacy of PEGylated Liposomal Cisplatin: In Vitro and In Vivo Evaluation M Ghaferi, MJ Asadollahzadeh, A Akbarzadeh, H Ebrahimi Shahmabadi, ... International Journal of Molecular Sciences 21 (2), 559, 2020 | 60 | 2020 |
| Preparation, characterization, and evaluation of cisplatin-loaded polybutylcyanoacrylate nanoparticles with improved in vitro and in vivo anticancer activities M Ghaferi, S Amari, B Vivek Mohrir, A Raza, H Ebrahimi Shahmabadi, ... Pharmaceuticals 13 (3), 44, 2020 | 54 | 2020 |
| Impact of PEGylated Liposomal Doxorubicin and Carboplatin Combination on Glioblastoma M Ghaferi, A Raza, M Koohi, W Zahra, A Akbarzadeh, ... Pharmaceutics 14 (10), 2183, 2022 | 44 | 2022 |
| Sortase A (SrtA) inhibitors as an alternative treatment for superbug infections S Alharthi, SE Alavi, PM Moyle, ZM Ziora Drug discovery today 26 (9), 2164-2172, 2021 | 44 | 2021 |
| Application of Mesoporous Silica Nanoparticles in Cancer Therapy and Delivery of Repurposed Anthelmintics for Cancer Therapy M Koohi Moftakhari Esfahani, SE Alavi, PJ Cabot, N Islam, EL Izake Pharmaceutics 14 (8), 1579, 2022 | 39 | 2022 |
| Anthelmintics for drug repurposing: Opportunities and challenges SE Alavi, HE Shahmabadi Saudi Pharmaceutical Journal 29 (5), 434-445, 2021 | 39 | 2021 |
| Camel milk as an alternative treatment regimen for diabetes therapy H Hussain, FH Wattoo, MHS Wattoo, M Gulfraz, T Masud, I Shah, S Ali, ... Food Science & Nutrition 9 (3), 1347-1356, 2021 | 39 | 2021 |
| Cisplatin-Loaded Polybutylcyanoacrylate Nanoparticles with Improved Properties as an Anticancer Agent SE Alavi, S Muflih Al Harthi, H Ebrahimi Shahmabadi, A Akbarzadeh International journal of molecular sciences 20 (7), 1531, 2019 | 36 | 2019 |
| Efficacy of Cisplatin-loaded poly butyl cyanoacrylate nanoparticles on the ovarian cancer: an in vitro study SK Bagherpour Doun, SE Alavi, M Koohi Moftakhari Esfahani, ... Tumor Biology 35, 7491-7497, 2014 | 35 | 2014 |
| Optimized Methods for the Production and Bioconjugation of Site-Specific, Alkyne-Modified Glucagon-like Peptide-1 (GLP-1) Analogs to Azide-Modified Delivery Platforms Using … SE Alavi, PJ Cabot, GY Yap, PM Moyle Bioconjugate Chemistry 31 (7), 1820-1834, 2020 | 34 | 2020 |
| PEG-grafted liposomes for enhanced antibacterial and antibiotic activities: An in vivo study SE Alavi, MKM Esfahani, A Raza, H Adelnia, HE Shahmabadi NanoImpact 25, 100384, 2022 | 31 | 2022 |
| Archaeosome: as new drug carrier for delivery of paclitaxel to breast cancer SE Alavi, H Mansouri, MKM Esfahani, F Movahedi, A Akbarzadeh, ... Indian Journal of Clinical Biochemistry 29, 150-153, 2014 | 31 | 2014 |
| Study of toxicity effect of pegylated nanoliposomal artemisinin on breast cancer cell line N Dadgar, SE Alavi, MKM Esfahani, A Akbarzadeh Indian Journal of Clinical Biochemistry 28, 410-412, 2013 | 31 | 2013 |
| Drug delivery of hydroxyurea to breast cancer using liposomes SE Alavi, MKM Esfahani, F Alavi, F Movahedi, A Akbarzadeh Indian Journal of Clinical Biochemistry 28, 299-302, 2013 | 31 | 2013 |
| Polybutylcyanoacrylate nanoparticles and drugs of the platinum family: Last status DRA Fatemeh, H Ebrahimi Shahmabadi, A Abedi, SE Alavi, F Movahedi, ... Indian Journal of Clinical Biochemistry 29, 333-338, 2014 | 29 | 2014 |
| PEGylated Mesoporous Silica Nanoparticles (MCM-41): A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostrate Cancer Cells MKM Esfahani, SE Alavi, PJ Cabot, N Islam, EL Izake Pharmaceutics 13 (10), 1605, 2021 | 28 | 2021 |
Hasan Ebrahimi ShahmabadiRafsanjan University of Medical Sciences在 rums.ac.ir 的电子邮件经过验证
